Encarna Cruz, general director of BioSim, comments in an interview with IM Farmacias about the intense activity of the Spanish Association of Biosimilar Medicines during the last year, especially in its work representing the sector, and the extensive dialogue developed with various sectors to communicate the advantages of biosimilars at the national level.
